Retrospective Analysis of Transarterial Radioembolization (TARE) with Phrenic Artery Occlusion

Retrospective Analysis of Transarterial Radioembolization (TARE) with Phrenic Artery Occlusion - TARE Phrenica

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037891

Enrollment

100

Registered

2025-09-12

Start date

2025-10-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Histologically confirmed primary or secondary liver tumor (C78.7

Interventions

Group 1: Retrospective Analysis of Transarterial Radioembolization (TARE) with Occlusion of the Phrenic Artery Data Sources Imaging datasets (CT, MRI, SPECT/PET, scintigraphy) and radiology reports r

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Histologically confirmed primary or secondary liver tumor Performance of TARE with occlusion of the phrenic artery within the specified period Complete documentation of treatment and follow-up data

Exclusion criteria

Exclusion criteria: Incomplete documentation

Design outcomes

Primary

Measure	Time frame
Progression-free survival (PFS) Radiologic response in the area supplied by the phrenic artery	—

Secondary

Measure	Time frame
Overall survival (OS) Incidence and severity of therapy-associated adverse events (CTCAE v5.0) Detectable perfusion redistribution (imaging-based)	—

Countries

Germany

Contacts

Public ContactThomas Dertnig

Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie

Thomas.Dertnig@uk-essen.de+4917641134629

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026